arrow
B

Brad E. Zacharia

Taipei Veterans General Hospital
H指数:43
被引数:6,938

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and effectiveness of stereotactic radiosurgery for larger hemangioblastomas (>2cc): A multi-center retrospective study

立体定向放射外科治疗较大血血管母细胞瘤(>2cc)的安全性和有效性:一项多中心回顾性研究

2026-04-170
OA
Single-Fraction Stereotactic Radiosurgery for Residual, Recurrent, or Metastatic Intracranial Solitary Fibrous Tumors: An IRRF Study Toward Management Guidance

单次立体定向放射外科治疗残留,复发或转移性颅内孤立性纤维瘤: 一项针对管理指导的IRRF研究

2026-01-270
OA
STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY

立体定向放射手术治疗卵巢癌脑转移:一项国际放射外科研究基金会回顾性研究

2025-10-010
OA
Analysis of transition metal content in glioblastoma reveals association between iron and survival

胶质母细胞瘤中过渡金属含量的分析揭示了铁与生存之间的关联

2025-05-010
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)
2024-11-110
PRE
EARLY SAFETY DATA FROM A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 2B STUDY OF IGV-001, AN AUTOLOGOUS CELL IMMUNOTHERAPY, VERSUS PLACEBO, IN NEWLY DIAGNOSED GLIOBLASTOMA
2024-10-170
PRE
Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma
2024-08-290
OAAI
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients
2023-12-078
OA
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)

小细胞和非小细胞肺癌脑转移的一线放射外科手术比较 (CROSS-FIRE)

2023-05-049
PRE
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study

立体定向放射外科治疗Koos IV级前庭神经鞘瘤: 一项多机构研究

2023-02-0126
OA
Effects of Neuroanatomic Structural Distances on Pituitary Function After Stereotactic Radiosurgery: A Multicenter Study

立体定向放射外科手术后神经解剖结构距离对垂体功能的影响: 一项多中心研究

2023-01-175
PRE
Plasma IL13Rα2 as a novel liquid biopsy biomarker for glioblastoma

血浆IL13Rα2作为胶质母细胞瘤的新型液体活检生物标志物

2022-11-275
PRE